Partner up with research
and engage in strategic research partnerships
The Amsterdam universities strongly encourage public-private research collaborations that drive innovation forward and have a positive impact on society. IXA is bridging the connection between Amsterdam academic and applied research and third parties. We call on companies, non-profits, governments, health care and educational institutions that are looking to innovate or find a different perspective to their approach to contact us. Our business developers will assist you.
Whether you are interested in sponsoring a research project, setting up a strategic alliance, or accessing laboratory facilities, we can help you engage in successful research partnerships.
Continue reading after the photo.
Successful collaborations start with the proper arrangements
We are aware that fruitful collaborations require an environment in which open discussion and exchange of information is safeguarded by a framework that respects the interests of all parties involved. Proper arrangements have to be made regarding ownership of research results, as well as rights to exploitation and publication. IXA has extensive experience in handling all legal and financial aspects concerning research collaborations. Our goal is to establish partnerships that offer true added value to all parties involved.
First drug developed by AMC spin-off reaches market
Medicin developed by Amsterdam UMC researchers, to treat life-threatening virus in newborns is ready for use.
News
Start-up Photosynthetic receives Eurostars grant and wins Formnext Start-Up Challenge
Photosynthetic, a VU tech start-up developing 3D lithography technology and founded by postdoctoral researcher and entrepreneur Alexander Kostenko, has not been sitting still in the past years.
News
ERC Proof of Concept Grant for VU chemist Tom Grossmann
Tom Grossmann, professor of Biomimetic Chemistry at VU Amsterdam, has been awarded a Proof of Concept grant by the European Research Council (ERC) for the project “Smart RNA delivery for therapy and diagnostic (grabRNA)”.
News